| ID physician / pharmacist rounding |
130 (82.3) |
| Audit and feedback for some ATBs prescribed |
119 (75.3) |
| Antimicrobials restricted to ID consultants |
113 (71.5) |
| Specific intervention for Surgical prophylaxis |
112 (70.9) |
| Specific intervention for Urinary tract infections |
93 (58.9) |
| Specific interventions for intraabdominal
infections |
91(57.6) |
| Time-sensitive Automatic Stop Order |
89 (56.3) |
| Specific intervention for community acquired
pneumonia |
86 (54.4) |
| Specific interventions for skin and soft tissue
infections |
82 (51.9) |
| ASP duration (n =49 ) |
|
| < 1 year |
5 (10.2) |
| 1 to 2 years |
3 (6.1) |
| 3 to 4 years |
1(2.0) |
| > 4 years |
13 (26.5) |
| Unsure |
27 (55.1 |
| Interaction frequency (n = 49) |
|
| Once or twice per week |
42 (85.7) |
| 3 to 4 times per week |
5 (10.2) |
| > 4 times per week |
2 (4.1) |
| Regular education programs (n=158) |
|
| Yes |
65 (41.1) |
| No |
93 (58.9) |
| Local antibiograms developed by hospital’s lab
(n=158) |
|
| Yes |
112 (70.9) |
| No |
46 (29.1) |
| Team composition (n=49) |
|
| Infectious disease physician |
47 (95.9) |
| ASP pharmacist |
31 (63.3) |
| Infection control officer |
32 (65.3) |
| Other |
7 (16.3) |
